Las Vegas, NV -- (SBWIRE) -- 01/06/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Horizon Pharma Inc(NASDAQ:HZNP), InvenSense Inc(NYSE:INVN), Cooper Tire & Rubber Co(NYSE:CTB), Merrimack Pharmaceuticals Inc(NASDAQ:MACK)
Horizon Pharma Inc(NASDAQ:HZNP) was a volume gainer of 2.84 million shares and the average volume of the stock remained 1.69 million shares. The stock opened the session at $7.60 and finished at the end of the day at $8.13 and the stock escalated 6.83%.The market capitalization of the stock remained 535.42 million. Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
For How Long HZNP will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, InvenSense Inc(NYSE:INVN) exchanged 2.74 million shares and the average volume remained 1.91 million shares. The stock closed the session at $20.54 with the gain of 2.65%. InvenSense, Inc. designs, develops, markets, and sells micro-electro-mechanical system (MEMS) gyroscopes for motion tracking devices in consumer electronics. The company delivers motion interface solutions based on its multi-axis gyroscope technology that target smartphones and tablets, console and portable video gaming devices.
Will INVN Continue To Move Higher? Find Out Here
Cooper Tire & Rubber Co(NYSE:CTB) enhanced 3.59% and its closing price was $24.79. The volume of the stock was 2.72 million shares and the average volume remained 1.56 million shares. The market capitalization of the stock remained 1.62 billion. The beta of the stock remained 2.35. Cooper Tire & Rubber Company, together with its subsidiaries, manufactures and markets replacement tires worldwide. It operates in two segments, North American Tire Operations and International Tire Operations. The International Tire Operations segment manufactures and markets passenger car, light truck, motorcycle, and racing tires and tire retread material. The company was founded in 1913 and is based in Findlay, Ohio.
Why Should Investors Buy CTB After The Recent Gain? Just Go Here and Find Out
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) exchanged 2.59 million shares in the previous trading session, and its average trading remained 2.47 million shares. MACK advanced 1.61% and it closed the trading at $5.68. The market capitalization of the stock remained 581.33 million. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States. The company uses its Network Biology proprietary systems biology-based approach to biomedical research.
For How Long MACK’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)